JOHN GIANGRECO: Open Payments
NPI 1457841892 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 10 payments from 5 companies in 2025. Trend: 2023 $23 · 2024 $57 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 3 | $89 |
| Astellas Pharma US Inc | 2 | $67 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $46 |
| Phadia US Inc. | 1 | $19 |
| Biogen, Inc. | 1 | $16 |
Products named: APRETUDE, Veozah, ImmunoCAP, ZURZUVAE.
Industry payments across NY — which companies pay providers there.
